July 3, 2026

MSOS Weekly Review | Jun 29–Jul 3, 2026

Weekly cannabis sector review from CannaSetups — observed conditions, not trade execution.

Executive Summary

MSOS posted a modest weekly gain, but the advance still looks selective rather than broad-based across the group.

MSOS added about 4.96% during the review week and remains roughly 38.42% above its three-month low.

Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.

DEA scheduling developments continued to move forward, although market reaction remained limited.

Key Takeaways

    • MSOS finished higher over Jun 29, 2026 – Jul 3, 2026.
    • Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.
    • DEA scheduling developments continued to move forward, although market reaction remained limited.

    Market Chart

    MSOS three-month daily price chart

    MSOS gained about 4.96% over Jun 29, 2026 – Jul 3, 2026, though the move still looks more like stabilization than a broad sector re-rating.

    Price remains roughly 38.42% above its three-month low, leaving the chart focused on whether the group can convert policy optimism into sustained institutional accumulation.

    Sector Performance

    MSOS
    +4.96% weekly · +3.25% 1Mo · 5.08
    TLRY
    -2.60% weekly · -18.51% 1Mo · 4.49
    CGC
    -4.45% weekly · -12.84% 1Mo · 0.95
    GTBIF
    +3.13% weekly · -1.98% 1Mo · 7.91
    CRLBF
    +2.29% weekly · -8.33% 1Mo · 0.83

    Breadth and Liquidity

    Participation was modestly positive, with advancers slightly outnumbering decliners. Breadth remained mixed, with fewer than half of tracked names above short- and intermediate-term trend measures. Liquidity was subdued, with average volume slightly lower, spreads relatively contained, and volatility moderate.

    What Changed

    DEA activity dominated cannabis policy discussion last week, with the agency advancing participant selection for the Schedule III rescheduling process. The market relevance is procedural: investors are tracking whether the hearing process can produce a clearer final-rule timeline for major U.S. operators.

    The market response remained muted, suggesting investors are still discounting procedural DEA steps until a clearer final-rule timeline emerges.

    State-level developments in Pennsylvania remained active, though most appear unlikely to materially change near-term earnings expectations for major U.S. operators.

    Rotation Watch

    MSOS remains well above its three-month low but below the upper end of its three-month range. Relative strength remained concentrated in MSOS and TLRY, while SNDL continued to lag. Leadership remains narrow rather than broadly constructive.

    Positioning and Sentiment

    Overall posture: Extended

    TrendStabilizing
    ParticipationMixed
    LiquiditySubdued
    Headline sensitivityElevated
    Institutional appetiteCautious

    What We'll Be Watching Next Week

    Next week’s tape will likely be shaped by whether policy headlines, breadth, and liquidity begin to confirm the recent stabilization.

    • Monitor whether MSOS can sustain closes above key moving averages after the latest weekly gain.
    • Watch whether advancers begin to outnumber decliners by a wider margin across the tracked universe.
    • Track whether dollar volume expands alongside price gains or fades into thinner trading conditions.
    • Follow developments from the DEA hearing and any scheduling, banking, or tax-related federal updates.
    • Track operator financing, guidance revisions, earnings updates, and exchange-related announcements for changes in relative strength leadership.
    • DEA scheduling developments — whether policy momentum becomes investable confirmation rather than procedural background

    Get the weekly cannabis sector desk review in your inbox.

    Policy developments, sector rotation, liquidity observations, and research workflow updates — delivered each week.

    CannaSetups provides market research and monitoring tools only. It does not provide brokerage services, trade execution, cannabis sales, or personalized financial advice.

    ← All newsletter issues